Advertisement

News Analysis

Most Recent

110m into post-genomic research

By | November 22, 2000

500,000 people will help research councils to solve post-genomic puzzles.

0 Comments

Children's parents sue hospital over genetics patent

By | November 22, 2000

Families of children suffering a degenerative brain disease are suing the hospital and researchers who used their children's blood and tissue to identify and patent the gene responsible for the disorder.

0 Comments

Italy: a GMO-free country?

By | November 21, 2000

The Italian Minister for Agricultural and Forestry Policy has made it clear he intends to ban GMOs of agricultural interest - but will he manage to sway the Italian public?

0 Comments

HOUSTON "Mosquitoes are flying syringes," declared Frank Cortez-Flores of Loma Linda University (California), and two mosquito-borne diseases have broken past old geographic boundaries to invade the US. The first, West Nile encephalitis, is a newcomer to the western hemisphere and thus has garnered the most headlines. The other, dengue fever, is considered the world's most important vector-borne viral disease affecting people, in terms of both morbidity and mortality. The West Nile virus, native

0 Comments

Nice and open

By | November 20, 2000

The UK's National Institute for Clinical Excellence has opted to remove confidentiality from its appraisal process as a means of pre-empting information leaks.

0 Comments

Patent knowledge

By | November 20, 2000

A special report just published in the UK reveals the extent and pace of the gene patent rush.

0 Comments

Nearly a million children die each year of malaria, but the parasite became resistant to the cheapest drug. Now we know why.

0 Comments

Modifying genetic research

By | November 15, 2000

GM food has provoked much protest but GM medicine has more public approval: the difference lies in approaches to research.

0 Comments

Many drugs effective against tropical diseases are no longer available or in danger of being pulled from the market because they are unprofitable.

0 Comments

Ritalin gets vote of approval in the UK

By | November 9, 2000

A new UK directive supports use of the controversial drug Ritalin in severe Attention Deficit/Hyperactivity Disorder (ADHD), but only under specialist supervision.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Teknova
Teknova
Advertisement
Life Technologies